These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27754800)

  • 1. Synthetic biology and occupational risk.
    Howard J; Murashov V; Schulte P
    J Occup Environ Hyg; 2017 Mar; 14(3):224-236. PubMed ID: 27754800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional Oversight of Occupational Health and Safety for Research Programs Involving Biohazards.
    Dyson MC; Carpenter CB; Colby LA
    Comp Med; 2017 Jun; 67(3):192-202. PubMed ID: 28662748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel.
    Miller JM; Astles R; Baszler T; Chapin K; Carey R; Garcia L; Gray L; Larone D; Pentella M; Pollock A; Shapiro DS; Weirich E; Wiedbrauk D; ;
    MMWR Suppl; 2012 Jan; 61(1):1-102. PubMed ID: 22217667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral-mediated gene therapy and genetically modified therapeutics: A primer on biosafety handling for the health-system pharmacist.
    Blind JE; McLeod EN; Campbell KJ
    Am J Health Syst Pharm; 2019 May; 76(11):795-802. PubMed ID: 31361814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant DNA technology: a 20-year occupational health retrospective.
    Cohen R; Hoerner CL
    Rev Environ Health; 1996; 11(3):149-65. PubMed ID: 9000305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deployment of Engineered Microbes: Contributions to the Bioeconomy and Considerations for Biosecurity.
    Parker MT; Kunjapur AM
    Health Secur; 2020; 18(4):278-296. PubMed ID: 32816583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biohazards in research laboratories].
    Porru S; Chiappin M; Sfriso N
    G Ital Med Lav Ergon; 2019 Dec; 41(4):359-364. PubMed ID: 32126610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
    Peng H; Bilal M; Iqbal HMN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30501091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation biocontainment systems for engineered organisms.
    Lee JW; Chan CTY; Slomovic S; Collins JJ
    Nat Chem Biol; 2018 Jun; 14(6):530-537. PubMed ID: 29769737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Vector Biosafety in Laboratory Animal Research.
    Collins DE; Reuter JD; Rush HG; Villano JS
    Comp Med; 2017 Jun; 67(3):215-221. PubMed ID: 28662750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic biology approaches to biological containment: pre-emptively tackling potential risks.
    Torres L; Krüger A; Csibra E; Gianni E; Pinheiro VB
    Essays Biochem; 2016 Nov; 60(4):393-410. PubMed ID: 27903826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
    Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
    Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic bugs on the loose: containment options for deeply engineered (micro)organisms.
    Schmidt M; de Lorenzo V
    Curr Opin Biotechnol; 2016 Apr; 38():90-6. PubMed ID: 26874261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recoded organisms engineered to depend on synthetic amino acids.
    Rovner AJ; Haimovich AD; Katz SR; Li Z; Grome MW; Gassaway BM; Amiram M; Patel JR; Gallagher RR; Rinehart J; Isaacs FJ
    Nature; 2015 Feb; 518(7537):89-93. PubMed ID: 25607356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
    Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate strains of human pathogens for field release.
    Park S; Kim CH; Jeong ST; Lee SY
    Bioengineered; 2018 Jan; 9(1):17-24. PubMed ID: 28692329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biosafety in laboratories concerning exposure to biological agents].
    Vonesch N; Tomao P; Di Renzi S; Vita S; Signorini S
    G Ital Med Lav Ergon; 2006; 28(4):444-56. PubMed ID: 17380946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Construction of a Biosafety Level 3 Autopsy Laboratory.
    Nolte KB; Muller TB; Denmark AM; Burstein R; Villalobos YA
    Arch Pathol Lab Med; 2021 Apr; 145(4):407-414. PubMed ID: 33307551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.